Avivagen, a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, has provided an update on the proof of concept work with its optioned technology for the permanent sterilization of female mammals - targeted to eliminate the need for surgical spaying.
READ MORE: Exploring the Non-Surgical Sterilization Conversation
This technology is intended to be effective for companion animal sterilization, control of feral and wild animal populations and certain livestock applications. It is drug-based and does not used methods described in published literature.
The proof of concept work did not demonstrate the intended sterilization effects. Avivagen and the inventor have analyzed the results and believe they may be due to issues with the drug actives, such as pharmacokinetic challenges. Avivagen has taken two actions to address this challenge to the project.
"While we'd hoped to succeed in this recent proof-of-concept work, we continue to believe in this approach and will move forward with determining the path to a successful trial," said Cameron Groome, CEO and President of Avivagen.
"We intend to update shareholders about our intentions with respect to this technology over the course of 2015."
For more information, please visit www.avivagen.com
No comments:
Post a Comment